Serenova A/S: Financial statements 2025
CVR: 30532228
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Serenova A/S (CVR 30532228) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -167,993 and a net result of DKK 38,663,045 compared with DKK -24,273,688 the year before. Equity in the 2025 report amounted to DKK 105,405,408. The solvency ratio was 89.6%.
- Gross Profit
- DKK -167,993
- Profit/Loss
- DKK 38,663,045
- Equity
- DKK 105,405,408
- Total Assets
- DKK 117,699,503
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -168K | 38.7M | 105.4M | 0 |
| 2024 | - | -586K | -24.3M | 66.7M | 1 |
| 2023 | - | -175K | 63.5M | 91M | 0 |
| 2022 | - | -202K | 6.9M | 27.5M | 1 |
| 2021 | - | -44K | 12.9M | 20.7M | 1 |
Official annual report
How creditworthy is Serenova A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Serenova A/S has published its annual report for 2024. Gross profit came to DKK -586,087, and the net result was DKK -24,273,688.
About Serenova A/S
Serenova A/S is a Danish company of the type Aktieselskab based in Solrød Strand, founded in 2008. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named SERENDEX PHARMACEUTICALS A/S and SERENDEX A/S. The management consists of Michael Aslo-Petersen. The company is owned by Sorana Holding A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -167,993 and a net result of DKK 38,663,045 compared with DKK -24,273,688 the year before. Equity in the 2025 report amounted to DKK 105,405,408.